Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A4I9V3
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0036094 | small molecule binding | 2 | 10 |
GO:0051287 | NAD binding | 4 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901265 | nucleoside phosphate binding | 3 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 101 | 103 | PF00675 | 0.213 |
CLV_NRD_NRD_1 | 199 | 201 | PF00675 | 0.549 |
CLV_NRD_NRD_1 | 29 | 31 | PF00675 | 0.296 |
CLV_NRD_NRD_1 | 60 | 62 | PF00675 | 0.213 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.310 |
CLV_PCSK_KEX2_1 | 29 | 31 | PF00082 | 0.246 |
CLV_PCSK_KEX2_1 | 60 | 62 | PF00082 | 0.227 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.219 |
CLV_PCSK_SKI1_1 | 106 | 110 | PF00082 | 0.212 |
DEG_APCC_DBOX_1 | 29 | 37 | PF00400 | 0.405 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.227 |
DOC_MAPK_gen_1 | 111 | 119 | PF00069 | 0.498 |
DOC_MAPK_gen_1 | 29 | 36 | PF00069 | 0.435 |
DOC_MAPK_gen_1 | 65 | 74 | PF00069 | 0.473 |
DOC_MAPK_MEF2A_6 | 113 | 121 | PF00069 | 0.391 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.340 |
DOC_USP7_MATH_1 | 193 | 197 | PF00917 | 0.279 |
DOC_USP7_MATH_1 | 22 | 26 | PF00917 | 0.527 |
DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.465 |
DOC_USP7_UBL2_3 | 65 | 69 | PF12436 | 0.459 |
LIG_14-3-3_CanoR_1 | 123 | 128 | PF00244 | 0.413 |
LIG_AP2alpha_2 | 21 | 23 | PF02296 | 0.424 |
LIG_BRCT_BRCA1_1 | 114 | 118 | PF00533 | 0.478 |
LIG_deltaCOP1_diTrp_1 | 17 | 23 | PF00928 | 0.465 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.446 |
LIG_LIR_Gen_1 | 115 | 125 | PF02991 | 0.410 |
LIG_LIR_Gen_1 | 21 | 28 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 115 | 121 | PF02991 | 0.418 |
LIG_LIR_Nem_3 | 17 | 23 | PF02991 | 0.446 |
LIG_PDZ_Class_2 | 199 | 204 | PF00595 | 0.351 |
LIG_Pex14_2 | 104 | 108 | PF04695 | 0.446 |
LIG_REV1ctd_RIR_1 | 101 | 110 | PF16727 | 0.427 |
LIG_REV1ctd_RIR_1 | 186 | 195 | PF16727 | 0.236 |
LIG_SH2_CRK | 38 | 42 | PF00017 | 0.450 |
LIG_SH2_GRB2like | 3 | 6 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 3 | 6 | PF00017 | 0.296 |
LIG_SUMO_SIM_anti_2 | 158 | 166 | PF11976 | 0.282 |
LIG_SUMO_SIM_par_1 | 158 | 166 | PF11976 | 0.317 |
LIG_TYR_ITIM | 36 | 41 | PF00017 | 0.422 |
LIG_UBA3_1 | 132 | 138 | PF00899 | 0.459 |
MOD_CK1_1 | 158 | 164 | PF00069 | 0.359 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.591 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.410 |
MOD_CK2_1 | 11 | 17 | PF00069 | 0.288 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.427 |
MOD_CK2_1 | 21 | 27 | PF00069 | 0.438 |
MOD_CK2_1 | 80 | 86 | PF00069 | 0.478 |
MOD_GlcNHglycan | 114 | 117 | PF01048 | 0.215 |
MOD_GlcNHglycan | 61 | 64 | PF01048 | 0.213 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.312 |
MOD_NEK2_1 | 169 | 174 | PF00069 | 0.472 |
MOD_NEK2_1 | 54 | 59 | PF00069 | 0.416 |
MOD_NEK2_1 | 80 | 85 | PF00069 | 0.478 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.440 |
MOD_PIKK_1 | 182 | 188 | PF00454 | 0.254 |
MOD_PK_1 | 123 | 129 | PF00069 | 0.459 |
MOD_PKA_1 | 137 | 143 | PF00069 | 0.406 |
MOD_PKA_2 | 174 | 180 | PF00069 | 0.340 |
MOD_PKA_2 | 59 | 65 | PF00069 | 0.413 |
MOD_Plk_1 | 80 | 86 | PF00069 | 0.478 |
MOD_Plk_4 | 155 | 161 | PF00069 | 0.381 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.459 |
MOD_SUMO_rev_2 | 62 | 67 | PF00179 | 0.479 |
TRG_ENDOCYTIC_2 | 38 | 41 | PF00928 | 0.422 |
TRG_ER_diArg_1 | 101 | 103 | PF00400 | 0.460 |
TRG_ER_diArg_1 | 28 | 30 | PF00400 | 0.446 |
TRG_ER_diArg_1 | 59 | 61 | PF00400 | 0.427 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4JA38 | Bodo saltans | 46% | 73% |
A0A3R7MNZ9 | Trypanosoma rangeli | 51% | 98% |
A0A422MS17 | Trypanosoma rangeli | 44% | 100% |
A0A422MS45 | Trypanosoma rangeli | 53% | 98% |
A0A422MS54 | Trypanosoma rangeli | 56% | 75% |
A4HAQ6 | Leishmania braziliensis | 68% | 100% |
E9B4W4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 87% | 69% |
E9B4W5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 100% |
P0C1E8 | Corynebacterium glutamicum (strain ATCC 13032 / DSM 20300 / BCRC 11384 / JCM 1318 / LMG 3730 / NCIMB 10025) | 35% | 67% |
P0C1E9 | Corynebacterium melassecola | 35% | 67% |
Q1QWN6 | Chromohalobacter salexigens (strain ATCC BAA-138 / DSM 3043 / CIP 106854 / NCIMB 13768 / 1H11) | 30% | 66% |
Q2VEQ7 | Haloferax mediterranei (strain ATCC 33500 / DSM 1411 / JCM 8866 / NBRC 14739 / NCIMB 2177 / R-4) | 36% | 66% |
Q9X1C1 | Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) | 34% | 67% |